EPA Revives Animal Testing Ban
Summary:
Trump’s EPA Administrator Lee Zeldin reinstates phaseout of animal testing by 2035, reversing Biden-era delays. Alternatives like NAMs are gaining traction despite controversy
Trump Administration Disrupts Research Landscape
Summary:
Mass firings of government scientists, grant terminations, and threatened budget cuts of up to 40% at NIH cause alarm among researchers worried about long-term damage to US science.
AI Protein Design Raises Security Concerns
Summary:
Scientists propose safeguards like FoldMark and “unlearning” to prevent AI protein design tools from being misused to create toxins or bioweapons while preserving benefits.
FDA Delays Decision on Rare Disease Treatment
Summary:
Stealth Biotherapeutics’ drug for Barth syndrome faces further FDA delays amid agency staffing cuts, despite prior priority review status and positive expert committee evaluation.
Pharma Giants Commit $158B to US Manufacturing
Summary:
J&J, Novartis, Lilly, and Roche announce massive investments in domestic facilities to avoid Trump tariffs, creating thousands of jobs across multiple states.
